Evidence map›Paper›PMID 41943918›Full record

ArticleBritish journal of haematology2026

Immunological features of acquired pure red cell aplasia: Specific human leucocyte antigen alleles, signal transducer and activator of transcription 3 mutations and a unique T-cell receptor beta motif.

Naruaki Yamashita, Toru Kawakami, Shuji Matsuzawa, Shotaro Miyairi, Masae Maruyama, Fumihiro Kawakami, Shunsuke Kojima, Ryu Yanagisawa, Yumiko Higuchi, Hideki Makishima and 2 more

Abstract read
In one paragraph

Article in British journal of haematology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Naruaki YamashitaDepartment of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan.ORCID https://orcid.org/0009-0001-1585-6704
Toru KawakamiDepartment of Haematology and Medical Oncology, Shinshu University School of Medicine, Matsumoto, Japan.ORCID https://orcid.org/0000-0003-0178-5332
Shuji MatsuzawaDepartment of Haematology and Medical Oncology, Shinshu University School of Medicine, Matsumoto, Japan.
Shotaro MiyairiDepartment of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan.
Masae MaruyamaDepartment of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan.
Fumihiro KawakamiDepartment of Haematology and Medical Oncology, Shinshu University School of Medicine, Matsumoto, Japan.
Shunsuke KojimaCentre for Advanced Cell Therapy, Shinshu University School of Medicine, Matsumoto, Japan.
Ryu YanagisawaCentre for Advanced Cell Therapy, Shinshu University School of Medicine, Matsumoto, Japan.
Yumiko HiguchiDepartment of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan.
Hideki MakishimaDepartment of Haematology and Medical Oncology, Shinshu University School of Medicine, Matsumoto, Japan.
Hideyuki NakazawaDepartment of Haematology and Medical Oncology, Shinshu University School of Medicine, Matsumoto, Japan.
Fumihiro IshidaDepartment of Clinical Laboratory Investigation, Graduate School of Medicine, Shinshu University, Matsumoto, Japan.

Funding

Hokuto Foundation for BioscienceJapan Society for the Promotion of Science, Grant-in-Aid for Scientific Research KAKENHI Number 21K16302Japan Society for the Promotion of Science, Grant-in-Aid for Scientific Research KAKENHI Number 25K11622
6 · The paper itself

Abstract

T-cell abnormalities have been implicated in the pathogenesis of acquired pure red cell aplasia (PRCA), particularly in its major subtypes such as idiopathic PRCA, thymoma-associated PRCA and large granular lymphocytic leukaemia (LGLL)-associated PRCA, and the precise details remain unclear. Furthermore, signal transducer and activator of transcription 3 (STAT3) mutations are frequently detected in PRCA patients, but their association with cellular immune abnormalities is not well understood. In order to elucidate the immunogenetic backgrounds of PRCA, we conducted human leucocyte antigen (HLA) typing in 39 PRCA patients. The results showed a significantly higher allele frequency of HLA-B*44:03:01, -C*14:03, -DRB1*13:02, compared to HLA database. Additionally, analysis of inferred HLA haplotypes revealed significantly increased frequencies of two haplotypes: HLA-A*24:02-C*07:02-B*07:02-DRB1*01:01 and -A*33:03-C*14:03-B*44:03:01-DRB1*13:02. Clonotypic analyses of T-cell receptor beta (TCRβ) chain revealed that 80% of the PRCA cases possessed mono- or oligoclonally expanded T cells. Particularly among those with STAT3 mutations, the 'QGXG' motif in 15 AA sequences of TCRβ complementarity-determining regions 3 (CDR3) regions was specifically recognized. These findings suggest that a specific immunogenetic background defined by particular HLA alleles, the expansion of somewhat limited T-cell clones and STAT3-mutated T cells are involved in the pathogenesis of chronic acquired PRCA.

Indexed as

HLA AntigensMutationReceptors, Antigen, T-Cell, alpha-betaRed-Cell Aplasia, PureSTAT3 Transcription FactorAdultAgedAged, 80 and overAllelesAmino Acid MotifsFemaleGene FrequencyHaplotypesHumansMaleMiddle AgedHLA AntigensReceptors, Antigen, T-Cell, alpha-betaSTAT3 protein, humanSTAT3 Transcription FactorHLApure red cell aplasiaSTAT3T‐cell receptor

Identifiers

PMID41943918
PMCPMC13176529

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.